Respons Bifasik dan Modulasi Indeks Aterogenik Ekstrak Etanol Moringa oleifera pada Model Zebrafish Diet-Induced Obesity: Sebuah Evaluasi Farmakologis
Statistik artikel
Data OJS dan sumber sitasiTayangan dan unduhan adalah aktivitas yang tercatat di OJS; pemrosesan statistik dapat tertunda. Tanda — berarti angka dari sumber tersebut belum tersedia. Cari di Google Scholar
Isi Artikel Utama
Abstrak
Latar Belakang: Dislipidemia terkait obesitas merupakan faktor risiko utama kardiovaskular. Moringa oleifera kaya akan fitosterol dan flavonoid yang berpotensi sebagai agen hipolipidemik. Namun, profil farmakodinamik dan respons bergantung-dosis (dose-dependent) pada model in vivo masih belum sepenuhnya dipahami, terutama terkait fenomena hormesis pada ekstrak kasar. Tujuan: Mengevaluasi efek modulasi profil lipid dan indeks aterogenik ekstrak etanol daun M. oleifera pada zebrafish model Diet-Induced Obesity (DIO). Metode: Zebrafish betina wild-type diinduksi obesitas melalui protokol overfeeding Artemia nauplii (model DIO) dan dialokasikan ke dalam lima kelompok (n=9-10 per kelompok pada analisis akhir): kontrol non-DIO, kontrol DIO, DIO + ekstrak 0,56 ppm, DIO + ekstrak 1,12 ppm, dan DIO + ekstrak 2,24 ppm. Setelah 40 hari, jaringan adiposa viseral diekstraksi untuk analisis kolorimetrik lipid. Indeks aterogenik (AI) dihitung sebagai proksi risiko kardiovaskular berbasis rasio lipoprotein. Hasil: Induksi DIO secara signifikan meningkatkan kolesterol total dan indeks aterogenik. Menariknya, ekstrak M. oleifera menunjukkan respons bifasik. Dosis 0,56 ppm secara signifikan merestorasi profil lipid dan menurunkan rasio LDL/HDL (AI) mendekati kelompok non-DIO (p<0,05), meskipun variabilitas antar-individu yang cukup besar pada dosis ini perlu diinterpretasi secara hati-hati. Sebaliknya, dosis 1,12 ppm gagal memperbaiki profil lipid dan justru memperburuk rasio aterogenik, yang secara tentatif mengindikasikan adanya batas terapeutik (therapeutic window) dan kemungkinan pergeseran ke arah pro-oksidan/stres metabolik pada dosis lebih tinggi. Pada dosis tertinggi (2,24 ppm), kolesterol total dan AI menunjukkan pemulihan parsial dibandingkan dosis 1,12 ppm; temuan sekunder ini kurang konsisten dibandingkan respons pada dosis 0,56 ppm dan memerlukan penelitian lebih lanjut sebelum diinterpretasikan secara mekanistik. Kesimpulan: Ekstrak etanol M. oleifera menunjukkan efek hipolipidemik yang paling konsisten pada dosis terendah yang diuji (0,56 ppm) melalui modulasi indeks aterogenik. Temuan ini menyoroti pentingnya standardisasi dosis serta karakterisasi toksikologis dan fitokimia lebih lanjut pada pengembangan fitofarmaka untuk menghindari efek paradoksikal
Rincian Artikel
Terbitan
Bagian

Artikel ini berlisensiCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Cara Mengutip
Referensi
WHO (World Health Organization). 2016. Obesity and Overweight. (http://www.who.int/mediacentre/factsheets/fs311/en/, diakses tanggal 11 November 2016).
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. 2013. Riset Kesehatan Dasar (Riskesdas) 2013. Jakarta.
Camp H.S., Ren D., Leff T. 2002. Adipogenesis and fat-cell function in obesity and diabetes. Trends in molecular medicine. 8 (9): 442-447.
Rayalam S., Della-Fera M. A., & Baile C. A. 2008. Phytochemicals and regulation of the adipocyte life cycle. The Journal of nutritional biochemistry. 19 (11): 717-726.
Dulloo A. G., Duret C., Rohrer D., Girardier L., Mensi N., Fathi M., Vandermander J. 1999. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. The American journal of clinical nutrition. 70 (6): 1040-1045.
Furuyashiki T., Nagayasu H., Aoki Y., Bessho H., Hashimoto T., Kanazawa K., Ashida H. 2004. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells. Bioscience, biotechnology, and biochemistry. 68 (11): 2353-2359.
Ahn J., Lee H., Kim S., Park J., dan Ha T. 2008. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochemical and biophysical research communications. 373 (4): 545-549.
Ahmed H., Metwally F., Rashad H., Zaazaa A., Ezzat S. M., Salama M. M. 2014. Moringa oleifera offers a multi-mechanistic approach for management of obesity in rats. International Journal of Pharmaceutical Sciences Review and Reearch. 29 (19): 98–106.
Bais S., Singh G., Sharma R. 2014. Antiobesity and Hypolipidemic Activity of Moringa oleifera Leaves against High Fat Diet-Induced Obesity in Rats. Advances in Biology, 2014.
Metwally F. M., Rashad H. M., Ahmed H. H., Mahmoud A. A., Raouf E. R. A., Abdalla, A. M. 2017. Molecular mechanisms of the anti-obesity potential effect of Moringa oleifera in the experimental model. Asian Pacific Journal of tropical biomedicine. 7 (3): 214-221.
Gopalakrishnan L., Doriya K., Kumar D. S. 2016. Moringa oleifera: A review on nutritive importance and its medicinal application. Food Science and Human Wellness. Beijing Academy of Food Sciences. 5 (2): 49–56.
Paul L. T., Fowler L. A., Barry R. J., Watts S. A. 2013. Evaluation of Moringa oleifera as a dietary supplement on growth and reproductive performance in zebrafish. Journal of nutritional ecology and food research. 1 (4): 322-328.
Rajanandh M.G. dan Kavitha J. 2010. Quantitative estimation of β-sitosterol, total phenolic and flavonoid compounds in the leaves of Moringa oleifera. International Journal of PharmTech Research. 2 (2): 1409-1414.
Jideani V.A. dan Diedericks C.F. 2014. Nutritional, therapeutic, and prophylactic properties of Vigna subterranea and Moringa oleifera. Antioxidant-antidiabetic agents and human health.
Al-Asmari A.K., Albalawi S.M., Athar M.T., Khan A.Q., Al-Shahrani H., Islam M. 2015. Moringa oleifera as an Anti-Cancer Agent Against Breast and Colorectal Cancer Cell Lines. PloS one. 10 (8): e0135814.
Leone A., Spada A., Battezzati A., Schiraldi A., Aristil J., Bertoli S. 2015. Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview. International Journal of Molecular Sciences. 16:12791-12835.
Aguirre L., Arias N., Macarulla M. T., Gracia A., Portillo M. P. 2011. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J. 4: 189-198.
Jung C.H., Cho I., Ahn, J., Jeon,T.I., dan Ha, T.Y. 2013. Quercetin reduces high‐fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytotherapy Research. 27 (1): 139-143.
Sergent T., Vanderstraeten J., Winand J., Beguin P., Schneider Y. 2012. Phenolic Compunds and Plant Extracts as Potential Natural Anti-Obesity Substances. Food Chemistry. 135: 68-73.
Moon J., Do H. J., Kim O. Y., Shin M. J. 2013. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food and chemical toxicology. 58: 347-354.
Fatema M.K., Chen Z.Y., Wei, G. 2015. β-sitosterol reduce cholesterol levels in high cholesterol diet fed zebrafish. International Journal of Natural and Social Sciences. 2: 53-65.
Meguro S., Hasumura T., Hase T. 2015. Body Fat Accumulation in Zebrafish is Induced by a Diet Rich in Fat and Reduced by Supplementation with Green Tea Extract. PloS one. 10: e0120142.
Oka T., Nishimura Y., Zang L., Hirano M., Shimada Y., Wang, Z., Umemoto N., Kuroyanagi J., Nishimura N., Tanaka T. 2010. Diet-Induced Obesity in Zebrafish Shares Common Pathophysiological Pathways with Mammalian Obesity. BMC Physiology. 10: 21.
Tainaka T., Shimada Y., Kuroyanagi J., Zang L., Oka T., Nishimura Y., Nishimura N., Tanaka T. 2011. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutrition & metabolism. 8 (1): 88.
Hasumura T., Shimada Y., Kuroyanagi J., Nishimura Y., Meguro S., Takema Y., dan Tanaka T. 2012. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish. Nutrition & Metabolism. 9: 73.
Sorgeloos P., Dhert P., Candreva P. 2001. Use of the brine shrimp, Artemia spp., in marine fish larviculture. Aquaculture. 200 (1): 147–159.
Reed B. dan Jennings M. 2011. Guidance on the housing and care of Zebrafish. Southwater: Royal Society for the Prevention of Cruelty to Animals.
Imrie D. dan Sadler K.C. 2010. White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Developmental Dynamics, 2010. 239 (11): 3013-3023.
Saeidnia S., Manayi A., Gohari A.R., dan Abdollahi M. 2014. The story of beta-sitosterol-a review. European Journal of Medicinal Plants. 4 (5): 590.
Baek J. S., Fang L., Li A. C., Miller Y. I. 2012. Ezetimibe and simvastatin reduce cholesterol levels in zebrafish larvae fed a high-cholesterol diet. Cholesterol.
Turley S. D. (2008). Role of Niemann-Pick C1–Like 1 (NPC1L1) in intestinal sterol absorption. Journal of clinical lipidology. 2 (2): S20-S28.
Fang L., Liu C., Miller Y. I. 2014. Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis. Translational Research. 163 (2): 99-108.
Babich H., Schuck A.G., Weisburg J.H., Zuckerbraun H.L. 2011. Research Strategies in the Study of the Pro-oxidant Nature of Polyphenol Nutraceuticals. Journal of Toxicology. 2011: 467305. doi:10.1155/2011/467305.
Jodynis-Liebert J. dan Kujawska M. 2020. Biphasic Dose-Response Induced by Phytochemicals: Experimental Evidence. Journal of Clinical Medicine. 9 (3): 718. doi:10.3390/jcm9030718.
Rosenson R.S., Brewer H.B. Jr., Ansell B.J., Barter P., Chapman M.J., Heinecke J.W., Kontush A., Tall A.R., Webb N.R. 2016. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nature Reviews Cardiology. 13 (1): 48-60.





